Bio Medica Laboratories Ltd PE Ratio

Bio Medica Laboratories PE Ratio

Image

Bio Medica Laboratories Ltd

NSE: BioMedicaLab

PE

-

Last updated on: May 29, 2026

Key Highlights

  • The P/E Ratio of Bio Medica Laboratories Ltd is 0 as of 29 May 26 The P/E Ratio of Bio Medica Laboratories Ltd changed from 0 on March 2023 to 0 on March 2025 . This represents a CAGR of 0.0% over 3 years .

Historical P/E Ratio of Bio Medica Laboratories Ltd

No data available

Company Fundamentals for Bio Medica Laboratories Ltd

Image

Bio Medica Laboratories Ltd

NSE: BioMedicaLab

Share Price

₹ -

Last updated on: Jan 01, 2026

Market Price of Bio Medica Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Bio Medica Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
29 May 2026115.8

BlinkX Score for Bio Medica Laboratories Ltd

Asset Value vs Market Value of Bio Medica Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PE Ratio of Bio Medica Laboratories Ltd Explained

0

Market cap

9

Earnings

0.0X

PE Ratio

Historical Market Cap of Bio Medica Laboratories Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Bio Medica Laboratories Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Bio Medica Laboratories Ltd

No data available

* All values are in %

About Bio Medica Laboratories Ltd

  • Bio Medica Laboratories Limited was originally incorporated as a private limited Company with the name of 'Bio Medica Laboratories Private Limited' vide certificate of Incorporation dated August 14, 2015, issued by Registrar of Companies, Gwalior.
  • Further, the status got converted into a Public Company & name of the Company changed from 'Bio Medica Laboratories Private Limited' to 'Bio Medica Laboratories Limited' & Registrar of Companies, CPC has issued a new Certificate of Incorporation dated October 24, 2024. Company is engaged in the of manufacturing of Pharmaceutical Parenteral Formulations.
  • It manufacture variety of products, comprising ethical drugs, generic drugs and over the-counter drugs (OTC) in the form of injectables namely Liquid Injections and Dry Powder Injections.
  • These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs.

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions